HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].

AuthorsIu B Belousov, O I Karpov, D Iu Belousov, A S Beketov
JournalTerapevticheskii arkhiv (Ter Arkh) Vol. 79 Issue 2 Pg. 58-66 ( 2007) ISSN: 0040-3660 [Print] Russia (Federation)
PMID17460971 (Publication Type: Lecture)
Chemical References
  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Antacids
  • Anti-Ulcer Agents
  • Histamine H2 Antagonists
  • Organometallic Compounds
  • Rabeprazole
  • Famotidine
  • Ranitidine
  • bismuth tripotassium dicitrate
  • Omeprazole
Topics
  • 2-Pyridinylmethylsulfinylbenzimidazoles (economics, therapeutic use)
  • Antacids (economics, therapeutic use)
  • Anti-Ulcer Agents (economics, therapeutic use)
  • Cost-Benefit Analysis
  • Drug Therapy, Combination
  • Famotidine (economics, therapeutic use)
  • Health Care Costs
  • Helicobacter Infections (epidemiology, microbiology)
  • Helicobacter pylori (isolation & purification)
  • Histamine H2 Antagonists (economics, therapeutic use)
  • Humans
  • Omeprazole (economics, therapeutic use)
  • Organometallic Compounds (economics, therapeutic use)
  • Peptic Ulcer (drug therapy, economics, epidemiology)
  • Rabeprazole
  • Ranitidine (economics, therapeutic use)
  • Russia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: